$ Value
$0
Shares
27,000
Price
$0
Filed
Jul 31
Insider
Name
Goldstein David M
Title
Chief Scientific Officer
CIK
0001751719
Roles
Transaction Details
Transaction Date
2025-07-29
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
29,115
Footnotes
Represents shares of common stock issuable upon settlement of a restricted stock unit ("RSU") grant. 25% of the shares underlying this RSU vest on August 1, 2026, and the remaining shares vest in equal quarterly installments thereafter over the following 12 quarters, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2024 Equity Incentive Plan) to the Issuer on each such vesting date. | Includes 2,115 shares acquired on May 20, 2025 under the Issuer's 2024 Employee Stock Purchase Plan. | Shares are held directly by the Baily Goldstein Living Trust dated March 4, 2014, for which the Reporting Person serves as a trustee. | Shares are held directly by family members of Reporting Person residing in his primary residence. | Shares are held directly by the Jacqueline Goldstein Trust dated September 17, 2019, for which the Reporting Person serves as trustee. Reporting Person became trustee on March 26, 2025 in a transaction that was exempt from reporting. | 25% of the shares underlying this option vest on July 29, 2026, and the remaining shares vest in equal monthly installments thereafter over the following 36 months, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2024 Equity Incentive Plan) to the Issuer on each such vesting date.
Filing Info
Other Insiders at ALMS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Tananbaum James B. | — | — | 2026-04-01 |
| Foresite Capital Management VI LLC | — | — | 2026-04-01 |
| Foresite Labs, LLC | — | — | 2026-04-01 |